Neurotrophic gene polymorphisms and response to psychological therapy

Kathryn Lester, J L Hudson, Maria Tropeano, C Creswell, David Collier, Anne Farmer, H. J. Lyneham, R. M. Rapee, Thalia Eley

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)

Abstract

Therapygenetics, the study of genetic determinants of response to psychological therapies, is in its infancy. Here, we investigate whether single-nucleotide polymorphisms in nerve growth factor (NGF) (rs6330) and brain-derived neutrotrophic factor (BDNF) (rs6265) genes predict the response to cognitive behaviour therapy (CBT). Neurotrophic genes represent plausible candidate genes: they are implicated in synaptic plasticity, response to stress, and are widely expressed in brain areas involved in mood and cognition. Allelic variation at both loci has shown associations with anxiety-related phenotypes. A sample of 374 anxiety-disordered children with white European ancestry was recruited from clinics in Reading, UK, and in Sydney, Australia. Participants received manualised CBT treatment and DNA was collected from buccal cells using cheek swabs. Treatment response was assessed at post-treatment and follow-up time points. We report first evidence that children with one or more copies of the T allele of NGF rs6330 were significantly more likely to be free of their primary anxiety diagnosis at follow-up (OR=0.60 (0.42–0.85), P=0.005). These effects remained even when other clinically relevant covariates were accounted for (OR=0.62 (0.41–0.92), P=0.019). No significant associations were observed between BDNF rs6265 and response to psychological therapy. These findings demonstrate that knowledge of genetic markers has the potential to inform clinical treatment decisions for psychotherapeutic interventions.
Original languageEnglish
Article numbere108
JournalTranslational psychiatry
Volume2
DOIs
Publication statusPublished - 1 May 2012

Fingerprint

Dive into the research topics of 'Neurotrophic gene polymorphisms and response to psychological therapy'. Together they form a unique fingerprint.

Cite this